It's highly scalable. They grow the number of stem cells form a single donor in a bioreactor so a single donor can service a huge number of people.
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-804
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.12 |
Change
0.018(1.58%) |
Mkt cap ! $1.250B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.13 | $1.08 | $1.767M | 1.617M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 21331 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 258430 | 15 |
View Market Depth
| Last trade - 12.51pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |